{"SPADE_UN_15308": {"basic": {"SPADE ID": "SPADE_UN_15308", "Peptide Name": 15, "Sequence": "YXG", "Source": "Synthetic", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HBL (1.6% inhibition at 1μM, 2.9% inhibition at 10μM, 5.9% inhibition at 100μM, 17.9% inhibition at 1000μM); SW620 (13.6% inhibition at 1μM, 20.4% inhibition at 10μM, 14.4% inhibition at 100μM, 23.4% inhibition at 1000μM); CaCo-2 (2.2% inhibition at 1μM, 4.2% inhibition at 10μM, 6.4% inhibition at 100μM, 6.2% inhibition at 1000μM); HEp-2 (2.7% inhibition at 1μM, 2% inhibition at 10μM, 18.8% inhibition at 100μM, 26.7% inhibition at 1000μM); MCF-7 (21.2% inhibition at 100μM); HT-29 (5.4% inhibition at 1μM, 7.4% inhibition at 10μM, 9.5% inhibition at 100μM, 15.7% inhibition at 1000μM); HeLa (9.8% inhibition at 1μM, 7.3% inhibition at 10μM, 9.9% inhibition at 100μM, 28.2% inhibition at 1000μM)", "Linear/Cyclic": "Linear", "Sequence Length": 3}, "extended_data_url": "SPADE_UN_15308_extended.json"}}